Recognizing and treating depression in patients with diabetes

被引：76

作者：

Rubin R.R. ^{[1
]}

Ciechanowski P. ^{[1
]}

Egede L.E. ^{[1
]}

Lin E.H.B. ^{[1
]}

Lustman P.J. ^{[1
]}

机构：

[1] Department of Medicine, Johns Hopkins Univ. School of Med., Baltimore, MD 21210

来源：

Current Diabetes Reports | 2004年 / 4卷 / 2期

关键词：

Glycemic Control; Primary Care Patient; Depression Treatment; Chronic Care Model; Primary Care Team;

D O I：

10.1007/s11892-004-0067-8

中图分类号：

学科分类号：

摘要：

Diabetes doubles the risk for depression, which in turn may interfere with effective diabetes self-management, and is associated with hyperglycemia and with increased risk for diabetes complications. Despite its relevance to the course of diabetes and its chronic character, depression is recognized and treated appropriately in fewer than 25% of depressed diabetic patients. The authors discuss the use of screening tools to assist primary care providers in identifying depressed diabetic patients, as well as the application of a chronic care model of depression management Data from controlled trials are limited but promising. They suggest that pharmacologic and psychological approaches are effective in the face of diabetes, and that successful treatment also produces improvements in glycemic control, overall functioning, and quality of life. Copyright © by Current Science Inc.

引用

页码：119 / 125

页数：6

共 54 条

[21]

Bellush L.L., Reid S.G., Metabolic and neurochemical profiles in insulin-treated diabetic rats, Am. J. Physiol., 266, (1994)

[22]

Bellush L.L., Reid S.G., North D., The functional significance of biochemical alterations in streptozotocin-induced diabetes, Physiol. Behav., 50, pp. 973-981, (1991)

[23]

Lustman P.J., Carney R.M., Santiago J.V., Cryer P.E., Stress and diabetic control, Lancet, 8324, (1983)

[24]

Lustman P.J., Clouse R.E., Carney R.M., Griffith L.S., Characteristics of depression in adults with diabetes, Proceedings from the NIMH Conference on Mental Disorders in General Health Care Settings, pp. 122-124, (1987)

[25]

Lustman P.J., Griffith L.S., Clouse R.E., Et al., Effects of nortriptyline on depression and glycemic control in diabetes: Results of a double-blind, placebo-controlled trial, Psychosom. Med., 59, pp. 241-250, (1997)

[26]

Lustman P.J., Freedland K.E., Griffith L.S., Clouse R.E., Fluoxetine for depression in diabetes: A randomized, double-blind, placebo-controlled trial, Diabetes Care, 23, pp. 618-623, (2000)

[27]

Lustman P.J., Griffith L.S., Freedland K.E., Et al., Cognitive behavior therapy for depression in type 2 diabetes: A randomized controlled trial, Ann. Intern. Med., 129, pp. 613-621, (1998)

[28]

Nielsen A.C., Williams T.A., Prevalence by self-report questionnaire and recognition by nonpsychiatric physicians, Arch. Gen. Psychiatry, 37, pp. 999-1004, (1980)

[29]

Wells K.B., Hays R.D., Burnam M.A., Et al., Detection of depressive disorder for patients receiving prepaid or fee- For-service care. Results from the Medical Outcomes Study, JAMA, 262, pp. 3298-3302, (1989)

[30]

Simon G., Von Korff M., Recognition and management of depression in primary care, Arch. Fam. Med., 4, pp. 99-105, (1995)

← 1 2 3 4 5 6 →